Importantly, our study reveals that GD2 expression on primary Th-MYCN tumor cells is stable through multiple rounds of engraftment and expansion, and provides proof-of-principle that transplant studies could facilitate detailed investigations of anti-NB immune activity and long-term protection. The gene discussed is MYCN; the disease is neuroblastoma.